A compound that is an active ingredient in plants commonly used in Chinese medicine prevents biofilm formation on polystyrene and polycarbonate surfaces by Staphylococcus aureus. The research suggests that this compound, 1,2,3,4,6-Penta-O-galloyl-beta-D-glucopyranose (PGG) is highly promising for clinical use in preventing biofilm formation by S. aureus. The paper is published in the March 2011 issue of the journal Antimicrobial Agents and Chemotherapy.
S. aureus commonly forms biofilms on medical implants, causing pneumonia, meningitis, endocarditis, osteomyelitis, and bloodstream and urinary tract infections. Biofilms, which are far tougher than bacteria not incorporated into biofilms, are resistant to antibiotics even when the individual bacteria composing the biofilm lack antibiotic resistance genes. Once biofilms become attached to the surfaces of medical devices, they are extremely difficult to expunge.
PGG is "far more potent" than several other compounds found to inhibit biofilms, including IDA, NAC, and NPM, according to the report. Despite that potency, PGG did not kill S. aureus. It is also non-toxic to human epithelial and fibroblast cells. PGG likely inhibits biofilm formation during the initial attachment stage, as the investigators found PGG to be effective only when it is added to a medium within an hour after seeding. Besides polystyrene and polycarbonates, PGG inhibited biofilm formation on silicon rubber, a material commonly used in catheters, and on glass coverslips.
PGG is an active ingredient in plants that are commonly used in Chinese medicine to treat inflammation. It was one of 48 compounds purified form medicinal plants that the researchers screened for efficacy in inhibiting S. aureus biofilm formation. PGG was on sole compound from among them that did not kill the pathogens.
Reference: M.-H. Lin, F.-R. Chang, M.-Y. Hua, Y.-C. Wu, and S.-T. Liu, 2011. Inhibitory effects of 1,2,3,4,6-Penta-O-Galloyl-beta-D-Glucopyranose on biofilm formation by Staphylococcus aureus. Antim. Agents Chemother. 55:1021-1027.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
Why Clinical Expertise Is the Cornerstone to Your Most Profitable Business Line
November 14th 2024Perioperative nurses bring vital skills in patient safety, infection control, and quality improvement. They enhance surgical outcomes and support health care systems during complex, high-risk procedures.
Meet Infection Control Today's Editorial Advisory Board Member: Rebecca Leach, MPH, BSN, RN, CIC
September 30th 2024Meet the experts shaping infection prevention: Infection Control Today's Editorial Board members share insights, experiences, and cutting-edge strategies to enhance health care safety and quality. Meet Rebecca Leach, MPH, BSN, RN, CIC.